HomeENGLISH MAGAZINEThe cancer dice is cast: youth stay fruitful, aging comes for reaping

The cancer dice is cast: youth stay fruitful, aging comes for reaping

The evidence against the traditional model of oncogenesis gets curiouser and curiouser. The saying “God doesn’t play dice” is meant to suggest that nothing happens by chance. On the other hand, cancer seems like the ultimate happenstance: Don’t we all have a 43-year-old, vegan, triathlete friend fighting cancer? Does this mean that cancer plays dice? According to the traditional model of how cancer develops, yes: Every time a cell divides, you roll a die, and the more years you roll, the greater your chance of rolling an unfortunate mutation that causes cancer. Some young people get very unlucky and some older people get very lucky, but overall, the longer you live, the more times you roll the die, the greater your risk of developing cancer. It makes perfect sense. Only, a University of Colorado Cancer Center study published in the journal eLife points out a simple problem with this model: Many cancers require more than one activating mutation. In other words, not only one but multiple unlikely bad things have to happen to cause cancer. Think of this like rolling multiple dice, or perhaps like rolling an unlucky number on a single die, multiple times. Say you’re rolling a 100-sided die with “42” being a cancer-causing mutation. You would expect it to take longer to roll four 42s than it does to roll one 42, right? But the current study shows that no matter the number of unlucky events needed to cause a specific kind of cancer, cancer risk rises equally with age. On average, it takes only one mutation to cause mesothelioma, and four mutations to cause pancreatic cancer and eleven mutations to cause colorectal cancer. Does anyone is willing to take the chance intentionally? No indeed.

But despite the dramatically different odds of “rolling” one, four and eleven “42s,” the incidence of these cancers goes up uniformly with age, accelerating from about age 60 to about age 85. In this case it does not, in fact, take longer to roll eleven 42s than it takes to roll one 42. Some cancers arise from giant pools of stem cells, while other cancers arise from very small ones. These larger stem cell pools are like rolling far more dice – sometimes thousands of times more dice – and when rolling more dice, you would expect to get the needed number of unfortunate 42s much more quickly than if rolling fewer dice. This means that cancers that grow from large stem cell pools should arise much earlier in life. They do not. Like the number of activating mutations, no matter the size of the stem cell pool, the incidence of most cancers rises uniformly with age. Also, whales have millions of times more cells than do mice, and yet cancer is no more common in whales than it is in mice – this lack of correlation between number of cells and cancer incidence is called Peto’s Paradox. Again, the point is that according to the traditional model of oncogenesis, it should take you longer to randomly generate four cancer-causing mutations than it takes you to generate one. And if you are rolling dice for a billion stem cells, generating these mutations should take less time than if you are rolling dice for a million stem cells. In reality, neither is true: Neither the number of activating mutations nor the size of the stem cell pool affects the age at which people develop these different kinds of cancer.

James DeGregori, PhD and CU Cancer Center Deputy Director, explained thoroughly: “What was really striking to us is that if you normalize all the cancer incidences, they all fall on top of each other – for different cancers that require such a different number of drivers and that arise from stem cell pools that range thousands of times in size, incidence is the same across age. What this means is that, mathematically, one cannot account for carcinogenesis simply with mutation accumulation over age. In other words, something other than the traditional model of oncogenesis is in play. Essentially what we show is that a logical way to get these patterns is to assume that selection for these mutations is disadvantageous in youth, but become advantageous later in life. If you think about the classic example of evolution, before the Industrial Revolution, it was advantageous for moths to be fairly light colored to match light-colored lichens on English trees. In pre-Industrial England, some moths were born black, but they were selected against. It was only when soot covered the trees that being dark colored became advantageous, allowing dark moths to out-compete light ones”. It seems somehow fitting that DeGregori’s answer to the questions of God and cancer playing dice comes from the field of evolution. And his methodology comes from, well, playing dice. What DeGregori means is that selection pressure acting on healthy cells and cancer cells competing in the ecosystem of the body – and not necessarily random, cancer-causing mutations – in large part decides who does and does not get cancer. In young people, cancer-causing mutations make a cell less fit for the tissue ecosystem; in older people, cancer-causing mutations make a cell more fit for the new, age-altered tissue ecosystem.

Like black moths, cancer cells may pop up from time to time in a young, healthy body, but they are generally selected against. It is only when old age, smoking (soot!), UV exposure or other carcinogenic factors adjust the tissue ecosystem that the black moths of cancer cells suddenly find themselves most fit. If these mutations are disadvantageous, they are disadvantageous in both large and small stem cell pools. And in terms of cancer risk, it matters less at what age you pick up the one or two or four needed cancer-causing mutations than at what age these mutations become advantageous. DeGregori calls this model of cancer driven by natural selection Adaptive Oncogenesis. And, in fact, cancer is not the only bad actor that takes advantage of tissue alterations that we experience at older ages. Dr. DeGregori concludes commenting positively: “The flip side is that youth is powerfully tumor suppressive. We are each composed of 30-40 trillion cells and we maintain this cooperative structure for more than half a century with minimal risk of cancer, even with all the exposures, all the cell divisions. It all comes down to how natural selection has invested in our bodies, simply as a means of maximizing return on investment – of investing in ensuring we reach reproductive age. Cancer reflects the waning of selection to maintain us”. Does God play dice? Ask the theologians and philosophers. As for cancer, it seems that it does play dice. But the dice are loaded. On a population level, rather than the fact of rolling a 42, what really affects cancer risk is how well adapted these dangerous number-42 cells are to their environment. In young, healthy tissues, 42 cells lose. In older tissues, they win.

It’s a game of deception. Bootstrap Bill: “Twelve fours! Call me a liar or up the bid”. Davy Jones: “And be called a liar for my trouble?” That’s what cancer would answer. Savvy?

  • Edited by Dr. Gainfrancesco Cormaci, PhD, specialist in Clinical Biochemistry.

Scientific references

Higa KC, DeGregori J. Aging Cell 2019 Jun; 18(3):e12938. 

Rozhok A, DeGregori J. Elife 2019 Apr 29; 8.

DeGregori J. Cancer Res. 2017; 77(22):6065-6068. 

Rozhok AI, DeGregori J. Trends Cancer 2016; 2(10):552. 

Dott. Gianfrancesco Cormaci
- Laurea in Medicina e Chirurgia nel 1998 (MD Degree in 1998) - Specialista in Biochimica Clinica nel 2002 (Clinical Biochemistry residency in 2002) - Dottorato in Neurobiologia nel 2006 (Neurobiology PhD in 2006) - Ha soggiornato negli Stati Uniti, Baltimora (MD) come ricercatore alle dipendenze del National Institute on Drug Abuse (NIDA/NIH) e poi alla Johns Hopkins University, dal 2004 al 2008. - Dal 2009 si occupa di Medicina personalizzata. - Guardia medica presso strutture private dal 2010 - Detentore di due brevetti sulla preparazione di prodotti gluten-free a partire da regolare farina di frumento immunologicamente neutralizzata (owner of patents concerning the production of bakery gluten-free products, starting from regular wheat flour). - Responsabile del reparto Ricerca e Sviluppo per la società CoFood s.r.l. (leader of the R&D for the partnership CoFood s.r.l.) - Autore di un libro riguardante la salute e l'alimentazione, con approfondimenti su come questa condizioni tutti i sistemi corporei. - Autore di articoli su informazione medica e salute sui siti web salutesicilia.com, medicomunicare.it e in lingua inglese sul sito www.medicomunicare.com
- Advertisment -